Literature DB >> 16441420

Phenotypic characterization of endometrial stromal sarcoma of the uterus.

Kazumi Yamada1, Junko Kano, Hajime Tsunoda, Hiroyuki Yoshikawa, Chigusa Okubo, Tadashi Ishiyama, Masayuki Noguchi.   

Abstract

Endometrial stromal sarcoma (ESS) of the uterus is a rare uterine malignancy that has not been characterized in detail. To characterize the phenotype of ESS of the uterus, we extracted RNA from ESS and the stroma of normal endometrium using a tissue microdissection system and compared the expression profiles in the two tissues. After suppression subtractive hybridization and differential screening, we detected the metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1) gene as one of the major genes upregulated in ESS, and a full-length placental cDNA clone (CS0DI066YJ10) as one of the major genes downregulated. The results were confirmed by in situ hybridization in four resected specimens of ESS and 36 biopsy specimens of normal endometrial tissue. All ESS (4/4) and all cases of endometrial stromal cells in the proliferative phase (13/13) were positive for MALAT-1, but samples of normal stroma in the secretory phase and menopausal state included some that were negative or weakly positive for MALAT-1 (5/13 and 3/10, respectively). In contrast, all ESS and 12 of 13 cases of stromal cells in the proliferative phase were negative for the full-length placental cDNA clone but 10 of 13 cases of endometrial stromal cells in the secretory phase were positive for transcripts of the gene (P < 0.05). These results indicated that endometrial stromal cells have different phenotypic characteristics between proliferative and secretory phases and the tumor cells of ESS have the phenotypic character of endometrial stromal cells in the proliferative phase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441420     DOI: 10.1111/j.1349-7006.2006.00147.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  66 in total

Review 1.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

2.  FARNA: knowledgebase of inferred functions of non-coding RNA transcripts.

Authors:  Tanvir Alam; Mahmut Uludag; Magbubah Essack; Adil Salhi; Haitham Ashoor; John B Hanks; Craig Kapfer; Katsuhiko Mineta; Takashi Gojobori; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

3.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Ming-chun Lai; Zhe Yang; Lin Zhou; Qian-qian Zhu; Hai-yang Xie; Feng Zhang; Li-ming Wu; Lei-ming Chen; Shu-sen Zheng
Journal:  Med Oncol       Date:  2011-06-16       Impact factor: 3.064

4.  RNA splicing control: yet another gene regulatory role for long nuclear noncoding RNAs.

Authors:  Xinying Zong; Vidisha Tripathi; Kannanganattu V Prasanth
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

5.  Long non-coding RNA MALAT-1 is downregulated in preeclampsia and regulates proliferation, apoptosis, migration and invasion of JEG-3 trophoblast cells.

Authors:  Haiying Chen; Tao Meng; Xuemin Liu; Manni Sun; Chunxiao Tong; Jing Liu; He Wang; Juan Du
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.

Authors:  Yongqiang Dong; Guojun Liang; Bo Yuan; Chaoqun Yang; Rui Gao; Xuhui Zhou
Journal:  Tumour Biol       Date:  2014-11-28

7.  Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma.

Authors:  Gu Qiu; Xiu-Bing Zhang; Shu-Qing Zhang; Pei-Long Liu; Wei Wu; Jin-Ye Zhang; Shi-Rong Dai
Journal:  Oncol Lett       Date:  2016-10-24       Impact factor: 2.967

Review 8.  MALAT1 -- a paradigm for long noncoding RNA function in cancer.

Authors:  Tony Gutschner; Monika Hämmerle; Sven Diederichs
Journal:  J Mol Med (Berl)       Date:  2013-03-26       Impact factor: 4.599

9.  Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer.

Authors:  Shou-Ping Xu; Jin-Feng Zhang; Shi-Yao Sui; Nan-Xia Bai; Song Gao; Guang-Wen Zhang; Qing-Yu Shi; Zi-Long You; Chao Zhan; Da Pang
Journal:  Tumour Biol       Date:  2015-07-10

10.  High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.

Authors:  Hong-Tu Zheng; De-Bing Shi; Yu-Wei Wang; Xin-Xiang Li; Ye Xu; Pratik Tripathi; Wei-Lie Gu; Guo-Xiang Cai; San-Jun Cai
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.